IMPAVIDO® is the first and only FDA-approved oral therapy for visceral, cutaneous, and mucosal leishmaniasis caused by specific Leishmania ...

Gilead Sciences and the World Health Organization (WHO) are doubling down on a pact to eliminate deadly parasitic disea | ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced a renewed five-year collaboration with the World Health Organization ...

Scientists have developed a new, safe and effective way to infect volunteers with the parasite that causes leishmaniasis and measure the body's immune response, bringing a vaccine for the neglected ...

"Leishmania Mutant Provides Insight Into Disease And May Lead To A Vaccine." ScienceDaily. www.sciencedaily.com / releases / 2003 / 09 / 030902074213.htm (accessed April 24, 2026).

WHO officials described the agreement as a major step forward in the global fight against neglected tropical diseases.

A tropical disease once seen almost exclusively among Americans returning from travel abroad now has a unique U.S. strain. Health officials warn that a related, deadlier parasite seen in other ...

A parasitic disease that can cause skin ulcers and is usually spread by the tiny sandfly may now be endemic to the U.S., preliminary findings from CDC researchers suggested. Genetic sequencing of ...

WHO and Gilead Sciences renew partnership to accelerate visceral leishmaniasis elimination: Geneva Friday, May 22, 2026, 14:00 Hrs [IST] The World Health Organization (WHO) and Gi ...